Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study

DSpace Repository

Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study

Author: Flaadt, Tim; Rehm, Jonas; Simon, Thorsten; Hero, Barbara; Ladenstein, Ruth L.; Lode, Holger N.; Grabow, Desiree; Nolte, Sandra; Crazzolara, Roman; Greil, Johann; Ebinger, Martin; Abele, Michael; Holzer, Ursula; Doering, Michaela; Schulte, Johannes H.; Bader, Peter; Schlegel, Paul-Gerhardt; Eyrich, Matthias; Lang, Peter; Klingebiel, Thomas; Handgretinger, Rupert
Tübinger Autor(en):
Flaadt, Tim
Rehm, Jonas
Ebinger, Martin
Abele, Michael
Holzer, Ursula
Schulte, Johannes H.
Lang, Peter
Handgretinger, Rupert
Döring, Michaela
Published in: Cancers (2025), Bd. 17 (1), Article 149
Verlagsangabe: Basel : Mdpi
Language: English
Full text: http://dx.doi.org/10.3390/cancers17010149
ISSN: 2072-6694
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)